Table 3.
Factors: | Proportion of variance in ADC predicted by these factors (LOOCV R2) |
---|---|
A. Hardware and acquisition parameters: | 64.3% |
Repetition time (TR)* | |
Echo time (TE)* | |
Flip angle | |
Pixel Bandwidth | |
In plane resolution* | |
Slice thickness | |
Number of signal averages (NSA)* | |
Maximum b-value* | |
Number of b-values* | |
Signal to noise ratio (SNR)* | |
Scanner model* | |
Magnetic field strength | |
B. Patient-intrinsic parameters | 0.4% |
Age | |
Sex | |
cT-stage (assessed on baseline MRI) | |
cN-stage (assessed on baseline MRI) | |
Response to chemoradiotherapy (complete versus incomplete response) | |
Tumor volume | |
C. Center | 32.5% |
Umbrella variable to account for any additional unknown variations between centers (e.g., patient preparation protocols, types of coils used, fat suppression techniques, etc.) | |
Significant parameters: center | |
All (A + B + C) combined | 63.5% |
Significant parameters: center, age, TR, TE, in-plane resolution, slice thickness, NSA, maximum b-values, number of b-values, scanner model, and SNR |
Further details of the regression analysis can be found in Supplementary Materials 2. The LOOCV R2 value is a leave-one-out cross-validated goodness-of-fit measure indicating the proportion of the variance in the dependent (i.e., ADC) variable that can be explained by the independent variables using a linear regression model
*Indicate the variables that were significant with a p value < 0.05 based on a likelihood ratio test. For continuous variables, all polynomial terms were tested jointly